Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000009/S127

Renamic Neo

Biotronik, Inc. · Decision date Apr 24, 2026

FDA DECISIONP000009/S127

What did the FDA approve?

FDA records P000009/S127 as a supplement to PMA P000009, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Apr 24, 2026.

FDA approval order statement

approval for display and programming head updates to Renamic Neo programmer
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Apr 24, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P000009/S127
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
APPR
Decision date
Apr 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P000009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000009 · Original PMA

    PHYLAX AV ICD SYSTEM

  2. P000009/S121 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  3. P000009/S122 · Related supplement

    Ilivia Neo 7 DR-T; Intica Neo 7 DR-T; Intica Neo 5 DR-T

  4. P000009/S123 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  5. P000009/S120 · Related supplement

    Acticor Sky DR-T 481987, Rivacor Sky DR-T 481982, Rivacor Rise DR-T 482018, Rivacor Aura DR-T 482014

  6. P000009/S127 received

    Application receipt date recorded by FDA.

  7. P000009/S127 · FDA decision

    Real-Time Process

  8. P000009/S129 · Related supplement

    Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T

  9. P000009/S131 · Related supplement

    Acticor Sky DR-T (481987); Rivacor Sky DR-T (481982); Rivacor Rise DR-T (482018); Rivacor Aura DR-T (482014)

  10. P000009/S130 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T

  11. P000009/S124 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  12. P000009/S133 · Related supplement

    Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T, Acticor 7 DR-T, Rivacor 7 DR-T, Rivacor 5 DR-T

  13. P000009/S132 · Related supplement

    Acticor Sky DR-T 481987; Rivacor Sky DR-T 481982; Rivacor Rise DR-T 482018; Rivacor Aura DR-T 482014

  14. P000009/S134 · Related supplement

    Intica Neo 7 DR-T DF-1 ProMRI, Intica Neo 5 DR-T DF-1 ProMRI

  15. P000009/S135 · Related supplement

    Ilivia Neo 7 DRT, Intica Neo 7 DRT, Intica Neo 5 DRT, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aur

Timeline entries are records held by MedtechLedger for P000009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000009

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik, Inc.PMA approvalSep 29, 2000FDA
Biotronik, Inc.PMA supplementSep 15, 2025FDA
Biotronik, Inc.PMA supplementOct 1, 2025FDA
Biotronik, Inc.PMA supplementOct 16, 2025FDA
Biotronik, Inc.PMA supplementDec 18, 2025FDA
Biotronik, Inc.PMA supplementFeb 3, 2026FDA
Biotronik, Inc.PMA supplementFeb 11, 2026FDA
Biotronik, Inc.PMA supplementMay 7, 2026FDA
Biotronik, Inc.PMA supplementJun 24, 2026FDA
Biotronik, Inc.PMA supplementSep 17, 2026FDA
Biotronik, Inc.PMA supplementSep 25, 2026FDA
Biotronik, Inc.PMA supplementSep 25, 2026FDA
Biotronik, Inc.PMA supplementOct 9, 2026FDA
Biotronik, Inc.PMA supplementOct 13, 2026FDA
BIOexpressP000009/S128
Biotronik, Inc.PMA supplementOct 16, 2026FDA
Biotronik, Inc.PMA supplementOct 22, 2026FDA

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records